Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Neurochem Res ; 39(8): 1502-10, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-24858241

RESUMO

It is well known that misfolded peptides/proteins can play a role in processes of normal ageing and in the pathogenesis of many diseases including Alzheimer's disease. Previously, we evaluated samples of cerebrospinal fluid from patients with Alzheimer's disease and multiple sclerosis by means of thioflavin-T-based fluorescence. We observed attenuated effects of magnetite nanoparticles operated via anti-aggregation actions on peptides/proteins from patients with Alzheimer's disease but not from those with multiple sclerosis when compared to age-related controls. In this study, we have evaluated the in vitro effects of anti-aggregation operating ferrofluid and phytoalexin spirobrassinin in the cerebrospinal fluid of patients with multiple sclerosis and Alzheimer's disease. We have found significant differences in native fluorescence (λ excitation = 440 nm, λ emission = 485 nm) of samples among particular groups (young controls < multiple sclerosis, Alzheimer's disease < old controls). Differences among groups were observed also in thioflavin-T-based fluorescence (young controls = multiple sclerosis < Alzheimer's disease < old controls) and the most marked change from native to thioflavin-T-based fluorescence was found in young controls (28-40 years old people). Both ferrofluid and spirobrassinin evoked drops in thioflavin-T-based fluorescence; however, ferrofluid was more efficient in old controls (54-75 years old people) and spirobrassinin in multiple sclerosis patients, both compared to young controls. The results are discussed especially in relation to aggregated peptides/proteins and liposoluble fluorescent products of lipid peroxidation. Based on the significant effect of spirobrassinin in vitro, we suggest that spirobrassinin may be of therapeutic value in multiple sclerosis.


Assuntos
Envelhecimento/líquido cefalorraquidiano , Cloretos/líquido cefalorraquidiano , Compostos Férricos/líquido cefalorraquidiano , Compostos Ferrosos/líquido cefalorraquidiano , Esclerose Múltipla/líquido cefalorraquidiano , Compostos de Espiro/líquido cefalorraquidiano , Tiazóis/líquido cefalorraquidiano , Adulto , Idoso , Benzotiazóis , Feminino , Fluorescência , Corantes Fluorescentes/análise , Humanos , Masculino , Pessoa de Meia-Idade , Esclerose Múltipla/diagnóstico
2.
Artigo em Inglês | MEDLINE | ID: mdl-8587775

RESUMO

Fe2+ and Zn2+ levels in perilymph of guinea pigs injected with gentamicin (GM) were examined and compared with the corresponding concentrations in CSF, serum and hairs. We observed a preventive and therapeutic action of sea buckthorn oil and injectio gastrodini to hearing loss. The results showed that: (1) the Fe2+ content in GM-injected guinea pigs was increased in perilymph and hairs; it was decreased after prevention and treatment, but there was no obvious change in CSF and serum; (2) the Zn2+ content in perilymph and CSF was increased in GM-injected guinea pigs. It rose further after prevention, but in serum and hairs it decreased. The results indicate that the ototoxic reaction to GM is related to the rise of the Fe2+ content in perilymph. The elevation of Zn2+ is a compensatory reaction. The changes in the chemical composition of perilymph are more important than those in CSF, serum and hairs for pathological changes of the cochlea. Sea buckthorn oil can prevent GM ototoxicity.


Assuntos
Álcoois Benzílicos , Transtornos da Audição/metabolismo , Ferro/análise , Perilinfa/química , Oligoelementos/análise , Vitamina A , Vitamina E , Vitamina K , Zinco/análise , Animais , Audiometria de Resposta Evocada , Limiar Auditivo/efeitos dos fármacos , Combinação de Medicamentos , Medicamentos de Ervas Chinesas/uso terapêutico , Compostos Ferrosos/análise , Compostos Ferrosos/sangue , Compostos Ferrosos/líquido cefalorraquidiano , Gentamicinas/efeitos adversos , Glucosídeos/uso terapêutico , Cobaias , Cabelo/química , Transtornos da Audição/sangue , Transtornos da Audição/líquido cefalorraquidiano , Transtornos da Audição/induzido quimicamente , Transtornos da Audição/prevenção & controle , Ferro/sangue , Ferro/líquido cefalorraquidiano , Óleos de Plantas/uso terapêutico , Inibidores da Síntese de Proteínas/efeitos adversos , Espectrofotometria Atômica , Oligoelementos/sangue , Oligoelementos/líquido cefalorraquidiano , Zinco/sangue , Zinco/líquido cefalorraquidiano
3.
Clin Sci (Lond) ; 82(3): 315-20, 1992 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-1372200

RESUMO

1. During pathological states of iron-overload or oxidant stress, low-molecular-mass iron can become available within extracellular fluids. 2. This iron would be converted to the ferrous state were it not for the protective anti-oxidant protein caeruloplasmin. 3. The ferrous-ion-oxidizing activity of caeruloplasmin rapidly converts ferrous ions back to the less reactive ferric state so that they can bind to available binding sites on transferrin. 4. Cerebrospinal fluids, however, often appear to contain low-molecular-mass iron, high levels of ascorbate and low levels of ferroxidase activity with little or no iron-binding capacity. 5. When iron ions are present in cerebrospinal fluid they are therefore likely to be in the ferrous state. 6. The development and application of an assay to speciate and measure ferrous ions in simple aqueous solution and their redox cycling activity in biological fluids is described.


Assuntos
Ferro/líquido cefalorraquidiano , Bleomicina , Dano ao DNA , Compostos Ferrosos/líquido cefalorraquidiano , Humanos , Masculino , Oxirredução , Sensibilidade e Especificidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...